{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T04:47:59Z","timestamp":1750308479442,"version":"3.41.0"},"publisher-location":"New York, NY, USA","reference-count":23,"publisher":"ACM","license":[{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.acm.org\/publications\/policies\/copyright_policy#Background"}],"funder":[{"name":"The Scientific Research and Sharing Platform Construction Project of Shaanxi Province","award":["2018PT-09"],"award-info":[{"award-number":["2018PT-09"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,5,27]]},"DOI":"10.1145\/3543377.3543391","type":"proceedings-article","created":{"date-parts":[[2022,8,8]],"date-time":"2022-08-08T16:13:52Z","timestamp":1659975232000},"page":"94-101","source":"Crossref","is-referenced-by-count":0,"title":["Pan-cancer analysis of CDCA2 and its function in papillary renal cell carcinoma"],"prefix":"10.1145","author":[{"given":"Fang","family":"Li","sequence":"first","affiliation":[{"name":"School of Basic Medical Sciences, Xi'an Jiaotong University, China"}]},{"given":"Qiuyu","family":"Jiang","sequence":"additional","affiliation":[{"name":"School of Basic Medical Sciences, Xi'an Jiaotong University, China"}]},{"given":"Jinyuan","family":"Zhang","sequence":"additional","affiliation":[{"name":"School of Basic Medical Sciences, Xi'an Jiaotong University, China"}]},{"given":"Xintao","family":"Jing","sequence":"additional","affiliation":[{"name":"School of Basic Medical Sciences, Xi'an Jiaotong University, China"}]},{"given":"Xiaofei","family":"Wang","sequence":"additional","affiliation":[{"name":"Biomedical Experimental Center, Xi'an Jiaotong University, China"}]},{"given":"Chen","family":"Huang","sequence":"additional","affiliation":[{"name":"School of Basic Medical Sciences, Xi'an Jiaotong University, China"}]}],"member":"320","published-online":{"date-parts":[[2022,8,8]]},"reference":[{"key":"e_1_3_2_1_1_1","first-page":"57","volume":"2000","author":"Hanahan D","unstructured":"Hanahan D , Weinberg RA: The hallmarks of cancer. Cell 2000 , 100(1): 57 - 70 . https:\/\/doi.org\/10.1016\/s0092-8674(00)81683-9 Hanahan D, Weinberg RA: The hallmarks of cancer. Cell 2000, 100(1):57-70. https:\/\/doi.org\/10.1016\/s0092-8674(00)81683-9","journal-title":"Cell"},{"key":"e_1_3_2_1_2_1","first-page":"2477","volume":"2005","author":"Cohen HT","unstructured":"Cohen HT , McGovern FJ: Renal-cell carcinoma. N Engl J Med 2005 , 353(23): 2477 - 2490 . https:\/\/doi.org\/10.1056\/NEJMra043172 Cohen HT, McGovern FJ: Renal-cell carcinoma. N Engl J Med 2005, 353(23):2477-2490. https:\/\/doi.org\/10.1056\/NEJMra043172","journal-title":"N Engl J Med"},{"key":"e_1_3_2_1_3_1","first-page":"124","volume":"2019","author":"Akhtar M","unstructured":"Akhtar M , Al-Bozom IA , Al Hussain T: Papillary Renal Cell Carcinoma (PRCC) : An Update. Adv Anat Pathol 2019 , 26(2): 124 - 132 . https:\/\/doi.org\/10.1097\/PAP.0000000000000220 Akhtar M, Al-Bozom IA, Al Hussain T: Papillary Renal Cell Carcinoma (PRCC): An Update. Adv Anat Pathol 2019, 26(2):124-132. https:\/\/doi.org\/10.1097\/PAP.0000000000000220","journal-title":"An Update. Adv Anat Pathol"},{"key":"e_1_3_2_1_4_1","volume-title":"Corrigendum to \"Systematic Review of Oncological Outcomes Following Surgical Management of Localised Renal Cancer\" [Eur Urol 2012;61:972-93]. Eur Urol","author":"MacLennan S","year":"2012","unstructured":"MacLennan S , Imamura M , Lapitan MC , Omar MI , Lam TB , Hilvano-Cabungcal AM : Corrigendum to \"Systematic Review of Oncological Outcomes Following Surgical Management of Localised Renal Cancer\" [Eur Urol 2012;61:972-93]. Eur Urol 2012 , 62(1):193. https:\/\/doi.org\/10.1016\/j.eururo.2012.04.003 MacLennan S, Imamura M, Lapitan MC, Omar MI, Lam TB, Hilvano-Cabungcal AM : Corrigendum to \"Systematic Review of Oncological Outcomes Following Surgical Management of Localised Renal Cancer\" [Eur Urol 2012;61:972-93]. Eur Urol 2012, 62(1):193. https:\/\/doi.org\/10.1016\/j.eururo.2012.04.003"},{"key":"e_1_3_2_1_5_1","volume-title":"The role of the CDCA gene family in ovarian cancer. Ann Transl Med","author":"Chen C","year":"2020","unstructured":"Chen C , Chen S , Luo M , Yan H , Pang L , Zhu C : The role of the CDCA gene family in ovarian cancer. Ann Transl Med 2020 , 8(5):190. https:\/\/doi.org\/10.21037\/atm.2020.01.99 Chen C, Chen S, Luo M, Yan H, Pang L, Zhu C : The role of the CDCA gene family in ovarian cancer. Ann Transl Med 2020, 8(5):190. https:\/\/doi.org\/10.21037\/atm.2020.01.99"},{"key":"e_1_3_2_1_6_1","first-page":"1385","volume":"2016","author":"Thang PM","unstructured":"Thang PM , Takano A , Yoshitake Y , Shinohara M , Murakami Y , Daigo Y: Cell division cycle associated 1 as a novel prognostic biomarker and therapeutic target for oral cancer. Int J Oncol 2016 , 49(4): 1385 - 1393 . https:\/\/doi.org\/10.3892\/ijo.2016.3649 Thang PM, Takano A, Yoshitake Y, Shinohara M, Murakami Y, Daigo Y: Cell division cycle associated 1 as a novel prognostic biomarker and therapeutic target for oral cancer. Int J Oncol 2016, 49(4):1385-1393. https:\/\/doi.org\/10.3892\/ijo.2016.3649","journal-title":"Int J Oncol"},{"key":"e_1_3_2_1_7_1","first-page":"2466","volume":"2020","author":"Li F","unstructured":"Li F , Zhang H , Li Q , Wu F , Wang Y , Wang Z : CDCA2 acts as an oncogene and induces proliferation of clear cell renal cell carcinoma cells. Oncol Lett 2020 , 19(3): 2466 - 2474 . https:\/\/doi.org\/10.3892\/ol.2020.11322 Li F, Zhang H, Li Q, Wu F, Wang Y, Wang Z : CDCA2 acts as an oncogene and induces proliferation of clear cell renal cell carcinoma cells. Oncol Lett 2020, 19(3):2466-2474. https:\/\/doi.org\/10.3892\/ol.2020.11322","journal-title":"Oncol Lett"},{"key":"e_1_3_2_1_8_1","volume-title":"Overexpression of cell cycle regulator CDCA3 promotes oral cancer progression by enhancing cell proliferation with prevention of G1 phase arrest. BMC Cancer","author":"Uchida F","year":"2012","unstructured":"Uchida F , Uzawa K , Kasamatsu A , Takatori H , Sakamoto Y , Ogawara K : Overexpression of cell cycle regulator CDCA3 promotes oral cancer progression by enhancing cell proliferation with prevention of G1 phase arrest. BMC Cancer 2012 , 12:321. https:\/\/doi.org\/10.1186\/1471-2407-12-321 Uchida F, Uzawa K, Kasamatsu A, Takatori H, Sakamoto Y, Ogawara K : Overexpression of cell cycle regulator CDCA3 promotes oral cancer progression by enhancing cell proliferation with prevention of G1 phase arrest. BMC Cancer 2012, 12:321. https:\/\/doi.org\/10.1186\/1471-2407-12-321"},{"key":"e_1_3_2_1_9_1","first-page":"5727","volume":"2020","author":"Wu B","unstructured":"Wu B , Huang Y , Luo Y , Ma A , Wu Z , Gan Y : The diagnostic and prognostic value of cell division cycle associated gene family in Hepatocellular Carcinoma. J Cancer 2020 , 11(19): 5727 - 5737 . https:\/\/doi.org\/10.7150\/jca.46554 Wu B, Huang Y, Luo Y, Ma A, Wu Z, Gan Y : The diagnostic and prognostic value of cell division cycle associated gene family in Hepatocellular Carcinoma. J Cancer 2020, 11(19):5727-5737. https:\/\/doi.org\/10.7150\/jca.46554","journal-title":"Hepatocellular Carcinoma. J Cancer"},{"key":"e_1_3_2_1_10_1","first-page":"173","volume":"2012","author":"Wurzenberger C","unstructured":"Wurzenberger C , Held M , Lampson MA , Poser I , Hyman AA , Gerlich DW: Sds22 and Repo-Man stabilize chromosome segregation by counteracting Aurora B on anaphase kinetochores. J Cell Biol 2012 , 198(2): 173 - 183 . https:\/\/doi.org\/10.1083\/jcb.201112112 Wurzenberger C, Held M, Lampson MA, Poser I, Hyman AA, Gerlich DW: Sds22 and Repo-Man stabilize chromosome segregation by counteracting Aurora B on anaphase kinetochores. J Cell Biol 2012, 198(2):173-183. https:\/\/doi.org\/10.1083\/jcb.201112112","journal-title":"J Cell Biol"},{"key":"e_1_3_2_1_11_1","volume-title":"Discovery of anthelmintic drug targets and drugs using chokepoints in nematode metabolic pathways. PLoS Pathog","author":"Taylor CM","year":"2013","unstructured":"Taylor CM , Wang Q , Rosa BA , Huang SC , Powell K , Schedl T : Discovery of anthelmintic drug targets and drugs using chokepoints in nematode metabolic pathways. PLoS Pathog 2013 , 9(8):e1003505. https:\/\/doi.org\/10.1371\/journal.ppat.1003505 Taylor CM, Wang Q, Rosa BA, Huang SC, Powell K, Schedl T : Discovery of anthelmintic drug targets and drugs using chokepoints in nematode metabolic pathways. PLoS Pathog 2013, 9(8):e1003505. https:\/\/doi.org\/10.1371\/journal.ppat.1003505"},{"key":"e_1_3_2_1_12_1","first-page":"R1012","volume":"2012","author":"Thadani R","unstructured":"Thadani R , Uhlmann F , Heeger S: Condensin, chromatin crossbarring and chromosome condensation. Curr Biol 2012 , 22(23): R1012 - R1021 . https:\/\/doi.org\/10.1016\/j.cub.2012.10.023 Thadani R, Uhlmann F, Heeger S: Condensin, chromatin crossbarring and chromosome condensation. Curr Biol 2012, 22(23):R1012-1021. https:\/\/doi.org\/10.1016\/j.cub.2012.10.023","journal-title":"Curr Biol"},{"key":"e_1_3_2_1_13_1","first-page":"387","volume":"2010","author":"Peng A","unstructured":"Peng A , Lewellyn AL , Schiemann WP , Maller JL: Repo-man controls a protein phosphatase 1-dependent threshold for DNA damage checkpoint activation. Curr Biol 2010 , 20(5): 387 - 396 . https:\/\/doi.org\/10.1016\/j.cub.2010.01.020 Peng A, Lewellyn AL, Schiemann WP, Maller JL: Repo-man controls a protein phosphatase 1-dependent threshold for DNA damage checkpoint activation. Curr Biol 2010, 20(5):387-396. https:\/\/doi.org\/10.1016\/j.cub.2010.01.020","journal-title":"Curr Biol"},{"key":"e_1_3_2_1_14_1","volume-title":"Identification of CDCA2 as a Diagnostic and Prognostic Marker for Hepatocellular Carcinoma. Front Oncol","author":"Yu Z","year":"2021","unstructured":"Yu Z , Zhang Y , Shao S , Liu Q , Li Y , Du X : Identification of CDCA2 as a Diagnostic and Prognostic Marker for Hepatocellular Carcinoma. Front Oncol 2021 , 11:755814. https:\/\/doi.org\/10.3389\/fonc.2021.755814 Yu Z, Zhang Y, Shao S, Liu Q, Li Y, Du X : Identification of CDCA2 as a Diagnostic and Prognostic Marker for Hepatocellular Carcinoma. Front Oncol 2021, 11:755814. https:\/\/doi.org\/10.3389\/fonc.2021.755814"},{"key":"e_1_3_2_1_15_1","first-page":"e108","volume":"2017","author":"Li T","unstructured":"Li T , Fan J , Wang B , Traugh N , Chen Q , Liu JS : TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells. Cancer Res 2017 , 77(21): e108 - e110 . https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-0307 Li T, Fan J, Wang B, Traugh N, Chen Q, Liu JS : TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells. Cancer Res 2017, 77(21):e108-e110. https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-0307","journal-title":"Tumor-Infiltrating Immune Cells. Cancer Res"},{"key":"e_1_3_2_1_16_1","first-page":"4368","volume":"2021","author":"Wang S","unstructured":"Wang S , Cao K , Liao Y , Zhang W , Zheng J , Li X : CDCA2 protects against oxidative stress by promoting BRCA1-NRF2 signaling in hepatocellular carcinoma. Oncogene 2021 , 40(25): 4368 - 4383 . https:\/\/doi.org\/10.1038\/s41388-021-01855-w Wang S, Cao K, Liao Y, Zhang W, Zheng J, Li X : CDCA2 protects against oxidative stress by promoting BRCA1-NRF2 signaling in hepatocellular carcinoma. Oncogene 2021, 40(25):4368-4383. https:\/\/doi.org\/10.1038\/s41388-021-01855-w","journal-title":"Oncogene"},{"key":"e_1_3_2_1_17_1","volume-title":"CDCA2 Inhibits Apoptosis and Promotes Cell Proliferation in Prostate Cancer and Is Directly Regulated by HIF-1alpha Pathway. Front Oncol","author":"Zhang Y","year":"2020","unstructured":"Zhang Y , Cheng Y , Zhang Z , Bai Z , Jin H , Guo X : CDCA2 Inhibits Apoptosis and Promotes Cell Proliferation in Prostate Cancer and Is Directly Regulated by HIF-1alpha Pathway. Front Oncol 2020 , 10:725. https:\/\/doi.org\/10.3389\/fonc.2020.00725 Zhang Y, Cheng Y, Zhang Z, Bai Z, Jin H, Guo X : CDCA2 Inhibits Apoptosis and Promotes Cell Proliferation in Prostate Cancer and Is Directly Regulated by HIF-1alpha Pathway. Front Oncol 2020, 10:725. https:\/\/doi.org\/10.3389\/fonc.2020.00725"},{"key":"e_1_3_2_1_18_1","volume-title":"CDCA2 promotes the proliferation of colorectal cancer cells by activating the AKT\/CCND1 pathway in vitro and in vivo. BMC Cancer","author":"Feng Y","year":"2019","unstructured":"Feng Y , Qian W , Zhang Y , Peng W , Li J , Gu Q : CDCA2 promotes the proliferation of colorectal cancer cells by activating the AKT\/CCND1 pathway in vitro and in vivo. BMC Cancer 2019 , 19(1):576. https:\/\/doi.org\/10.1186\/s12885-019-5793-z Feng Y, Qian W, Zhang Y, Peng W, Li J, Gu Q : CDCA2 promotes the proliferation of colorectal cancer cells by activating the AKT\/CCND1 pathway in vitro and in vivo. BMC Cancer 2019, 19(1):576. https:\/\/doi.org\/10.1186\/s12885-019-5793-z"},{"key":"e_1_3_2_1_19_1","first-page":"882","volume":"2021","author":"Li J","unstructured":"Li J , Chen Y , Wang X , Wang C: CDCA2 triggers in vivo and in vitro proliferation of hepatocellular carcinoma by activating the AKT\/CCND1 signaling. J BUON 2021 , 26(3): 882 - 888 . Li J, Chen Y, Wang X, Wang C: CDCA2 triggers in vivo and in vitro proliferation of hepatocellular carcinoma by activating the AKT\/CCND1 signaling. J BUON 2021, 26(3):882-888.","journal-title":"J BUON"},{"key":"e_1_3_2_1_20_1","first-page":"282","volume":"2014","author":"Else T","unstructured":"Else T , Kim AC , Sabolch A , Raymond VM , Kandathil A , Caoili EM : Adrenocortical carcinoma. Endocr Rev 2014 , 35(2): 282 - 326 . https:\/\/doi.org\/10.1210\/er.2013-1029 Else T, Kim AC, Sabolch A, Raymond VM, Kandathil A, Caoili EM : Adrenocortical carcinoma. Endocr Rev 2014, 35(2):282-326. https:\/\/doi.org\/10.1210\/er.2013-1029","journal-title":"Endocr Rev"},{"key":"e_1_3_2_1_21_1","volume-title":"Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun","author":"Yoshihara K","year":"2013","unstructured":"Yoshihara K , Shahmoradgoli M , Martinez E , Vegesna R , Kim H , Torres-Garcia W : Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun 2013 , 4:2612. https:\/\/doi.org\/10.1038\/ncomms3612 Yoshihara K, Shahmoradgoli M, Martinez E, Vegesna R, Kim H, Torres-Garcia W : Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun 2013, 4:2612. https:\/\/doi.org\/10.1038\/ncomms3612"},{"key":"e_1_3_2_1_22_1","volume-title":"Comprehensive Analysis of CDCAs Methylation and Immune Infiltrates in Hepatocellular Carcinoma. Front Oncol","author":"Wang Y","year":"2020","unstructured":"Wang Y , Yang Y , Gao H , Ouyang T , Zhang L , Hu J : Comprehensive Analysis of CDCAs Methylation and Immune Infiltrates in Hepatocellular Carcinoma. Front Oncol 2020 , 10:566183. https:\/\/doi.org\/10.3389\/fonc.2020.566183 Wang Y, Yang Y, Gao H, Ouyang T, Zhang L, Hu J : Comprehensive Analysis of CDCAs Methylation and Immune Infiltrates in Hepatocellular Carcinoma. Front Oncol 2020, 10:566183. https:\/\/doi.org\/10.3389\/fonc.2020.566183"},{"key":"e_1_3_2_1_23_1","first-page":"6858","volume":"2020","author":"Jin WH","unstructured":"Jin WH , Zhou AT , Chen JJ , Cen Y: CDCA2 promotes proliferation and migration of melanoma by upregulating CCAD1. Eur Rev Med Pharmacol Sci 2020 , 24(12): 6858 - 6863 . https:\/\/doi.org\/10.26355\/eurrev_202006_21675 Jin WH, Zhou AT, Chen JJ, Cen Y: CDCA2 promotes proliferation and migration of melanoma by upregulating CCAD1. Eur Rev Med Pharmacol Sci 2020, 24(12):6858-6863. https:\/\/doi.org\/10.26355\/eurrev_202006_21675","journal-title":"Eur Rev Med Pharmacol Sci"}],"event":{"name":"ICBBT 2022: 2022 14th International Conference on Bioinformatics and Biomedical Technology","acronym":"ICBBT 2022","location":"Xi'an China"},"container-title":["2022 14th International Conference on Bioinformatics and Biomedical Technology"],"original-title":[],"link":[{"URL":"https:\/\/dl.acm.org\/doi\/10.1145\/3543377.3543391","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/dl.acm.org\/doi\/pdf\/10.1145\/3543377.3543391","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T18:43:11Z","timestamp":1750272191000},"score":1,"resource":{"primary":{"URL":"https:\/\/dl.acm.org\/doi\/10.1145\/3543377.3543391"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,27]]},"references-count":23,"alternative-id":["10.1145\/3543377.3543391","10.1145\/3543377"],"URL":"https:\/\/doi.org\/10.1145\/3543377.3543391","relation":{},"subject":[],"published":{"date-parts":[[2022,5,27]]}}}